Zsolt Hepp

1.9k total citations · 1 hit paper
54 papers, 1.3k citations indexed

About

Zsolt Hepp is a scholar working on Surgery, Epidemiology and Oncology. According to data from OpenAlex, Zsolt Hepp has authored 54 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Surgery, 19 papers in Epidemiology and 12 papers in Oncology. Recurrent topics in Zsolt Hepp's work include Bladder and Urothelial Cancer Treatments (30 papers), Urinary and Genital Oncology Studies (12 papers) and Multiple and Secondary Primary Cancers (11 papers). Zsolt Hepp is often cited by papers focused on Bladder and Urothelial Cancer Treatments (30 papers), Urinary and Genital Oncology Studies (12 papers) and Multiple and Secondary Primary Cancers (11 papers). Zsolt Hepp collaborates with scholars based in United States, United Kingdom and France. Zsolt Hepp's co-authors include Sepideh F. Varon, Emily Beth Devine, Ryan N. Hansen, Patrick Gillard, David W. Dodick, Lisa Bloudek, Jenny Chia, Ved V. Gossain, Ramon Espaillat and Maureen J. Lage and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Annals of Oncology.

In The Last Decade

Zsolt Hepp

51 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adherence to oral migraine-preventive medications among patients with chronic migraine

2014 323 citations Zsolt Hepp, Patrick Gillard et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zsolt Hepp United States	13	883	589	266	234	93	54	1.3k
Mike D. Smith United States	6	322 0.4×	121 0.2×	343 1.3×	90 0.4×	158 1.7×	12	1.0k
Yen‐Ho Wang Taiwan	16	213 0.2×	321 0.5×	78 0.3×	102 0.4×	58 0.6×	35	880
M. Navez France	12	167 0.2×	161 0.3×	455 1.7×	88 0.4×	21 0.2×	22	706
Jesús Castillo Spain	14	910 1.0×	500 0.8×	318 1.2×	137 0.6×	20 0.2×	25	1.1k
Kevin L. Billups United States	22	1.0k 1.1×	96 0.2×	58 0.2×	142 0.6×	893 9.6×	36	1.6k
Parvez Shirazi United States	16	147 0.2×	115 0.2×	176 0.7×	154 0.7×	34 0.4×	33	856
Jonathan P. Gladstone Canada	19	982 1.1×	577 1.0×	313 1.2×	167 0.7×	28 0.3×	46	1.4k
Elena Polverejan United States	10	275 0.3×	60 0.1×	132 0.5×	124 0.5×	30 0.3×	19	692
José W. Geurts Netherlands	22	180 0.2×	610 1.0×	384 1.4×	334 1.4×	9 0.1×	38	1.7k
Sarah Peirce‐Sandner United States	7	230 0.3×	150 0.3×	370 1.4×	211 0.9×	19 0.2×	7	1.2k

Countries citing papers authored by Zsolt Hepp

Since Specialization

Citations

This map shows the geographic impact of Zsolt Hepp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zsolt Hepp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zsolt Hepp more than expected).

Fields of papers citing papers by Zsolt Hepp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zsolt Hepp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zsolt Hepp. The network helps show where Zsolt Hepp may publish in the future.

Co-authorship network of co-authors of Zsolt Hepp

This figure shows the co-authorship network connecting the top 25 collaborators of Zsolt Hepp. A scholar is included among the top collaborators of Zsolt Hepp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zsolt Hepp. Zsolt Hepp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morgans, Alicia K., Guru Sonpavde, Phoebe Wright, et al.. (2024). REAL-WORLD ELIGIBILITY AND UTILIZATION OF AVELUMAB MAINTENANCE IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA. Urologic Oncology Seminars and Original Investigations. 42. S26–S27.

Morgans, Alicia K., Phoebe Wright, Zsolt Hepp, et al.. (2024). Real-World Treatment Patterns and Clinical Outcomes in Patients With Locally Advanced or Metastatic Urothelial Carcinoma by Eligibility for Maintenance Avelumab. Clinical Genitourinary Cancer. 23(1). 102270–102270. 1 indexed citations

Apolo, Andrea B., Nicholas I. Simon, Simrun Grewal, et al.. (2023). Understanding drivers of treatment preferences in locally advanced or metastatic urothelial carcinoma: A qualitative interview study with patients, caregivers, and physicians.. Journal of Clinical Oncology. 41(6_suppl). 492–492. 3 indexed citations

Morgans, Alicia K., Matthew D. Galsky, Phoebe Wright, et al.. (2023). Real-world treatment patterns and clinical outcomes with first-line therapy in patients with locally advanced/metastatic urothelial carcinoma by cisplatin-eligibility. Urologic Oncology Seminars and Original Investigations. 41(8). 357.e11–357.e21. 12 indexed citations

Bloudek, Lisa, Phoebe Wright, Caroline McKay, et al.. (2023). Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of First-Line Therapies (1L) for Locally Advanced/Metastatic Urothelial Carcinoma (la/mUC). Current Oncology. 30(4). 3637–3647. 8 indexed citations

Galsky, Matthew D., et al.. (2023). Benchmarking Maintenance Therapy Survival in First-Line Platinum-Based Chemotherapy–Treated Patients with Advanced Urothelial Carcinoma Using Simulated Disease Modeling. Clinical Epidemiology. Volume 15. 765–773. 2 indexed citations

McGregor, Bradley A., Peter H. O’Donnell, Arjun Vasant Balar, et al.. (2022). Health-related Quality of Life of Patients with Locally Advanced or Metastatic Urothelial Cancer Treated with Enfortumab Vedotin after Platinum and PD-1/PD-L1 Inhibitor Therapy: Results from Cohort 1 of the Phase 2 EV-201 Clinical Trial. European Urology. 81(5). 515–522. 20 indexed citations

Galsky, Matthew D., et al.. (2022). Treatment with opioids in patients with locally advanced or metastatic urothelial carcinoma and matched non-cancer controls. Urologic Oncology Seminars and Original Investigations. 40(9). 411.e9–411.e18. 2 indexed citations

Hepp, Zsolt, Maureen J. Lage, Ramon Espaillat, & Ved V. Gossain. (2021). The direct and indirect economic burden of hypothyroidism in the United States: a retrospective claims database study. Journal of Medical Economics. 24(1). 440–446. 18 indexed citations

10.

Wirtz, Heidi S., et al.. (2021). PCN118 Estimated Prevalence of Treated Locally Advanced or Metastatic Urothelial Carcinoma in Canada Using Simulation Modeling. Value in Health. 24. S41–S41. 1 indexed citations

11.

Morgans, Alicia K., Matt D. Galsky, Zsolt Hepp, et al.. (2021). 704P Treatment patterns among patients with advanced urothelial carcinoma (aUC) in the USA. Annals of Oncology. 32. S714–S715. 6 indexed citations

12.

Morgans, Alicia K., Zsolt Hepp, Sonali N. Shah, et al.. (2021). Real-world burden of illness and unmet need in locally advanced or metastatic urothelial carcinoma following discontinuation of PD-1/L1 inhibitor therapy: A Medicare claims database analysis. Urologic Oncology Seminars and Original Investigations. 39(10). 733.e1–733.e10. 9 indexed citations

13.

Lage, Maureen J., et al.. (2020). Levothyroxine Treatment of Pregnant Women with Hypothyroidism: Retrospective Analysis of a US Claims Database. Advances in Therapy. 37(2). 933–945. 10 indexed citations

14.

Hepp, Zsolt, et al.. (2020). PCN326 Qualitative Analysis of PAIN in Patients with Locally Advanced or Metastatic Urothelial Cancer. Value in Health. 23. S480–S480.

15.

Lage, Maureen J., et al.. (2020). Hypothyroidism Treatment Among Older Adults: Evidence from a Claims Database. Advances in Therapy. 37(5). 2275–2287. 4 indexed citations

16.

McGovern, Andrew, et al.. (2018). PCN108 - TARGETED LITERATURE REVIEW OF THE BURDEN OF ILLNESS IN UROTHELIAL CARCINOMA. Value in Health. 21. S32–S33. 2 indexed citations

17.

Keyloun, Katelyn R., Ryan N. Hansen, Zsolt Hepp, et al.. (2017). Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD). CNS Drugs. 31(5). 421–432. 65 indexed citations

18.

Hepp, Zsolt, et al.. (2016). Cost Effectiveness of Onabotulinumtoxina Versus Ptns and Sns for the Treatment of Overactive Bladder from the US Payer Perspective. Value in Health. 19(3). A130–A131. 2 indexed citations

19.

Hepp, Zsolt, et al.. (2016). Characterizing Health Care Utilization, Direct Costs, and Comorbidities Associated with Interstitial Cystitis: A Retrospective Claims Analysis. Value in Health. 19(3). A130–A130. 7 indexed citations

20.

Hepp, Zsolt, Sara Forrester, J. Scott Roth, Heidi S. Wirtz, & Emily Beth Devine. (2013). Cost-Effectiveness Of A Computerized Provider Order Entry System In Improving Medication Safety: A Case Study In Ambulatory Care. Value in Health. 16(3). A205–A206. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact